EMA is the European Medicines Agency decentralised of the European Union. EMA is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union.
Since 2010, EUnetHTA and EMA have been in regular contact to exchange information and discuss various issues of mutual interest.
The cooperation started with a project on improving EPARs followed by discussions and concrete cooperation on the following topics:
Discussions take place at the bi-annual meetings between the EUnetHTA and EMA representatives, via participation of EMA as observer in relevant activities of the EUnetHTA Joint Actions (2010-2012 and 2012-2015), by mutual commenting on specific documents produced by either of the organisation.
EUnetHTA and its members participate in the EMA-supported ENCePP network.
Read more about EMA
This website was produced under the Third EU Health Programme through a service contract with the European Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission. The information and views set out in this website are those of the author(s) and do not necessarily reflect the official opinion of the Commission/Executive Agency. The Commission/Executive Agency do not guarantee the accuracy of the data included in this website. Neither the Commission/Executive Agency nor any person acting on the Commission’s/Executive Agency’s behalf may be held responsible for the use which may be made of the information contained therein.
©2021 EUnetHTA All rights reserved.